You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TdT positive adult acute lymphoblastic leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

Recruiting
  • B-Cell Lymphoblastic Leukemia
  • Acute Lymphoblastic Leukemia
  • Tampa, Florida
    Moffitt Cancer Center
Nov 28, 2023

B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • HY004
  • +2 more
  • (no location specified)
Aug 18, 2023

Acute Lymphoblastic Leukemia Trial in Ann Arbor (Dasatinib, Ponatinib, Berlin-Frankfurt-Münster Chemotherapy)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Nov 28, 2022

Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult, Acute Lymphoblastic Leukemia, Adult Trial in Zhuhai (Thiotepa,

Recruiting
  • Burkitt Lymphoma
  • +2 more
  • Thiotepa, cyclophosphamide, cladribine, and cytarabine conditioning regimen
  • Zhuhai, Guangdong, China
    The Fifth Affiliated Hospital of Sun Yat-sen University
Sep 25, 2023

Acute Lymphoblastic Leukemia Trial (inotuzumab ozogamicin)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • inotuzumab ozogamicin
  • (no location specified)
Jan 6, 2023

Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

Recruiting
  • Non-hodgkin Lymphoma
  • +2 more
  • CC312
  • Tianjin, Tianjin, China
    InstituteHBDH
Sep 12, 2023

Survival in Adult MRD Positive Acute Lymphoblastic Leukemia

Completed
  • Acute Lymphoblastic Leukemia
    • Brno, Czechia
    • +9 more
    Sep 12, 2022

    Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)

    Recruiting
    • Acute Lymphoid Leukemia
    • +3 more
    • São Paulo, SP, Brazil
      Instituto do Cancer do Estado de Sao Paulo
    Jul 24, 2023

    Determining the Mechanisms of Loss of CAR T Cell Persistence

    Not yet recruiting
    • Acute Lymphoblastic Leukemia With Failed Remission
    • +4 more
      • (no location specified)
      Mar 29, 2023

      Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Trial in Tianjin (Vincristine, Daunorubicin, Cyclophosphamide)

      Recruiting
      • Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
      • Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Dec 13, 2022

      Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • +5 more
      • CD19 specific Chimeric Antigen Receptor T Cell
      • Columbus, Ohio
        Nationwide Children's Hospital
      Mar 9, 2023

      Acute Lymphoblastic Leukemia (ALL) Trial (Nilotinib)

      No longer available
      • Acute Lymphoblastic Leukemia (ALL)
      • (no location specified)
      Aug 5, 2022

      B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

      Not yet recruiting
      • B Acute Lymphoblastic Leukemia
      • +2 more
      • Azacitidine Injection
      • +2 more
      • (no location specified)
      Oct 15, 2023

      Acute Lymphoblastic Leukemia, Adult, Invasive Fungal Infections Trial in Rome (observation of invasive fungal infections)

      Recruiting
      • Acute Lymphoblastic Leukemia, Adult
      • Invasive Fungal Infections
      • observation of invasive fungal infections
      • Rome, Italy
        Fondazione Policlinico Universitario A. Gemelli IRCCS
      Feb 20, 2023

      Acute Undifferentiated Leukemia, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia Trial

      Completed
      Has Results
      • Acute Undifferentiated Leukemia
      • +13 more
      • Chicago, Illinois
        Cancer and Leukemia Group B
      Apr 5, 2022

      T-Acute Lymphoblastic Leukemia, Adult T Lymphoblastic Lymphoma Trial in United States (BL-8040, Nelarabine)

      Terminated
      • T-Acute Lymphoblastic Leukemia
      • Adult T Lymphoblastic Lymphoma
      • Saint Louis, Missouri
      • +1 more
      Jan 18, 2023

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

      Recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +7 more
      • Blinatumomab
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 31, 2022

      Clinical Significance of Occult Central Nervous System

      Recruiting
      • Acute Lymphoblastic Leukemia
      • cerebrospinal fluids exams
      • Roma, RM, Italy
        Tor Vergata University
      Mar 17, 2023

      Acute Lymphoblastic Leukemia Trial in Sanhe (CAR-NK-CD19 Cells)

      Completed
      • Acute Lymphoblastic Leukemia
      • CAR-NK-CD19 Cells
      • Sanhe, Hebei, China
        Hebei Yanda Ludaopei Hospital
      Nov 24, 2022

      Acute Lymphoblastic Leukemia Trial in New York (Venetoclax)

      Recruiting
      • Acute Lymphoblastic Leukemia
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Feb 2, 2023

      Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

      Active, not recruiting
      • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 2, 2022

      Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Positive Trial in New York (Blinatumomab, dasatinib, dexamethasone)

      Recruiting
      • Acute Lymphoblastic Leukemia
      • Philadelphia Chromosome-Positive
      • Blinatumomab
      • +3 more
      • New York, New York
      • +1 more
      Nov 10, 2022

      Patients Who Received Inotuzumab Ozogamicin for B-cell ALL That

      Not yet recruiting
      • Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
      • Inotuzumab Ozogamicin
      • (no location specified)
      Nov 3, 2022

      Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Frankfurt (Imatinib, Ponatinib, Blinatumomab)

      Recruiting
      • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
      • Frankfurt, Germany
        Department of Medicine, Hematology and Oncology, Goethe Universi
      Sep 24, 2023

      Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

      Suspended
      • Juvenile Myelomonocytic Leukemia
      • +27 more
      • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
      • +2 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 11, 2023